Navigation Links
The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
Date:3/11/2008

WASHINGTON, March 11 /PRNewswire/ -- Proteome Systems Ltd. (ASX: PXL) CEO Dr Jenny Harry has been invited to join a panel with world health leaders in Washington DC at the Partnering for Global Health Forum sponsored by the Bill & Melinda Gates Foundation and organised by Bio Ventures in Global Health, and BIO the Biotechnology Industry Organization. [March 10-12, 2008]. http://pgh.bio.org/opencms/PGH/2008/program/program.jsp

The Forum follows a report last month from the World Health Organization (WHO) revealing that drug resistant tuberculosis has hit the highest levels ever recorded. According to a survey of over 90,000 TB patients in 81 countries, the WHO found that levels of multi-drug resistant (MDR) TB were far higher then expected. The survey also found cases in 45 countries of extensively drug resistant TB, which is virtually untreatable.

At the DC Forum Dr Harry is participating in a panel which will address 'Needs and Opportunities in Diagnostics: Creating Sustainable Solutions for the Developing World', and will draw on Proteome Systems' experience in its current development program for a rapid and accurate TB diagnostic test.

Proteome System's test aims to directly detect active TB by the presence of TB in the human body allowing for effective and timely treatment. It is planned that the test will diagnose TB within minutes, whereas the current tests for active TB take days to weeks. This will be a significant benefit in the management of this highly infectious disease.

The WHO estimates that there is an annual need for over 193 million point-of-care diagnostic tests for TB.

Proteome Systems has a collaboration and licensing agreement to advance the development and commercialization of the active TB diagnostic tests.

According to the US National Institute of Health, 8 million people worldwide, mostly in poorer countries wh
'/>"/>

SOURCE Proteome Systems Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Hank Plain Joins Morgenthaler Ventures as Partner
2. Dan Broderick Joins Prolog Ventures as Partner
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. Khosla Ventures and BIOeCON Form KiOR Inc.
6. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
7. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
8. Clarus Ventures Closes $660 Million Fund
9. Global Experts Explore Entire Spectrum of Aids Vaccine Development
10. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... SoundConnect , an award winning unified communications ... Darren Suders has joined the team as Director of ... partner program through innovative offerings, consistent partner ... brings more than 10-years of channel telecommunication experience to ... from policy development, to partner education and to expansion. ...
(Date:11/26/2014)... , Nov. 25, 2014 Bio-Techne Corporation ... has appointed Robert Gavin to serve in ... the Protein Platforms Division.  Mr. Gavin will be responsible ... segment, which includes the ProteinSimple business acquired in July ... San Jose, California -based ProteinSimple develops ...
(Date:11/24/2014)... -- Five American winners will receive the ... for Medical Sciences", in its 8 th term; ... , on 15 December 2014.      (Photo: ... Center which won the Hamdan Award for Volunteers in ... that aim to improve health and promote peace and ...
(Date:11/24/2014)... Nov. 24, 2014   Veracyte, Inc. (Nasdaq: ... , president and chief executive officer, will present in a ... Annual Healthcare Conference on Tuesday, December 2, 2014 at 12:30 ... The live audio webcast and subsequent replay may be ... connect to the website at least 15 minutes prior to ...
Breaking Biology Technology:SoundConnect Appoints Director of Channel Development & Sales 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3Five US Winners Among Recipients of Hamdan Medical Awards 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2
... 13, 2011 Tengion, Inc. (NASDAQ: TNGN ... new data from the Company,s Neo-Urinary Conduit™ (NUC) and ... at the TERMIS North America Annual Conference being held ... NUC program is further supported by various cellular and ...
... Dec. 13, 2011  Astellas Pharma Inc. (Tokyo: 4503, Astellas) ... from an interim analysis of a Phase 2 study ... were presented at the 53rd Annual Meeting of the ... Data were also presented from two additional posters: one ...
... PHILADELPHIA, Dec. 13, 2011 Tarsa Therapeutics today confirmed ... Application (NDA) to the Food and Drug Administration (FDA) ... company,s oral recombinant salmon calcitonin tablet for the treatment ... the FDA that verified the results from Tarsa,s Phase ...
Cached Biology Technology:Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 2Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 3Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 2Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 3Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 5Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 6Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 7Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 8Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 2Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 3
(Date:11/4/2014)... only marketing directed at children on the interior ... that the majority of black, middle-income and rural ... , Authored by Arizona State University researcher Punam ... first to examine the use of child-directed marketing ... restaurants and its relationship to demographics. It adds ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and Markets ... "Cell Therapy - Technologies, Markets and Companies" to their ... therapy technologies and methods, which have already started to play ... cell transplantation is replacing the old fashioned bone marrow transplants. ... therapy is bound to become a part of medical practice. ...
(Date:11/2/2014)... of Physics World , James Dacey explores the ... death" to take their innovations from the lab into ... challenge facing all start-up companies as they move from ... of two main factors: physics-based inventions are usually far ... out to be a lot more complicated than had ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3The 'valley of death' facing physics start-ups 2
... human survival and food security, especially as population density ... social insects to cultivate crops, have harvested plant material ... years. New results from the Smithsonian show that both ... coming into the nest inside leaves, thus ensuring the ...
... year, hundreds of thousands of people suffer medical complications ... skin. A new device developed by MIT engineers and ... needles on target. The device, which is purely ... industry. It involves a hollow S-shaped needle containing a ...
... has joined with a team of colleagues to propose ... research field that investigates heritable alterations in gene expression ... Dr. Shilatifard,s publication appeared today in ... meeting on December 7-10, 2008 that he co-organized at ...
Cached Biology News:Food security for leaf-cutting ants: Workers and their fungus garden reject endophyte invaders 2MIT: Novel needle could cut medical complications 2Ali Shilatifard and colleagues aim to clarify the definition of 'epigenetics' 2
... Kit, 500 reactions. Prepare circular DNA ... h.Generate microgram quantities of template DNA ... amplified DNA directly for cycle sequencing ... M13 liquid cultures, colonies, plaques, or ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
This Universal 24" X 18" (61 X 45.7cm.) shaker platforms will accept any Thermo Forma shaker flask clip....
Biology Products: